Archives of Virology

, Volume 105, Issue 1–2, pp 15–27 | Cite as

Partial deletion of the human host range gene in the attenuated vaccinia virus MVA

  • W. Altenburger
  • C-P. Süter
  • Judit Altenburger
Original Papers


The genome of a strongly attenuated vaccinia virus strain, MVA, was investigated by Southern blot and sequence analyses. Three major deletions, relative to the WR strain, were localized in MVA DNA. The deletions occurred near both ends of the viral genome and one of them affected a 55 K as well as the 32 K human host range gene. Although more than two thirds of the host range gene were eliminated from the MVA, the virus could still multiply in certain human cells.


Infectious Disease Sequence Analysis Human Cell Southern Blot Host Range 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Betholet CR, Drillien R, Wittek R (1985) One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proc Natl Acad Sci USA 82: 2096–2100Google Scholar
  2. 2.
    Buller RML, Smith GL, Cremer K, Notkins AL, Moss B (1985) Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinasenegative phenotype. Nature 317: 813–815Google Scholar
  3. 3.
    Buller RML, Chakrabarti S, Cooper JA, Twardizik DR, Moss B (1988) Deletion of the vaccinia virus growth factor gene reduces virus virulence. J Virol 62: 866–874Google Scholar
  4. 4.
    Cooper JA, Wittek R, Moss B (1981) Extension of the transcriptional and translational map of the left end of the vaccinia virus genome to 21 kilobase pairs. J Virol 39: 733–745Google Scholar
  5. 5.
    Dales S, Pogo BGT (1981) Biology of poxviruses. Virol Monogr 18: 1–109Google Scholar
  6. 6.
    Dallo S, Esteban M (1987) Isolation and characterization of attenuated mutants of vaccinia virus. Virology 159: 408–422Google Scholar
  7. 7.
    DeFilippes FM (1982) Restriction enzyme mapping of vaccinia virus DNA. J Virol 43: 136–149Google Scholar
  8. 8.
    Dekking F (1973) Attenuated vaccinia strain for primary vaccination of adults in nonendemic countries. Symp Series Immunobiol Standard 19: 293–297Google Scholar
  9. 9.
    Drillien R, Koehren F, Kirn A (1981) Host range deletion mutant of vaccinia virus defective in human cells. Virology 111: 488–499Google Scholar
  10. 10.
    Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988) Smallpox and its eradication. World Health Organization, GenevaGoogle Scholar
  11. 11.
    Gillard S, Spehner D, Drillien R, Kirn A (1986) Localization and sequence of the vaccinia virus gene required for multiplication in human cells. Proc Natl Acad Sci USA 83: 5573–5577Google Scholar
  12. 11a.
    Holzner A (1976) Zur Beurteilung der MVA-Stufenimpfung bei Pockenerstimpfungen. Ph.D. Thesis, University of Munich, Federal Republic of GermanyGoogle Scholar
  13. 12.
    Joklik K (1962) The purification of four strains of poxvirus. Virology 18: 9–18Google Scholar
  14. 13.
    Mackett M, Smith GL, Moss B (1982) Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci USA 79: 7415–7419Google Scholar
  15. 14.
    Maniatis T, Fritsch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NYGoogle Scholar
  16. 15.
    Mayr A, Danner K (1979) Bedeutung von Tierpocken für den Menschen nach Aufhebung der Pflichtimpfung gegen Pocken. Berl Münch Tierärztl Wochenschr 92: 251–256Google Scholar
  17. 16.
    Mayr A Hochstein-Mintzel V, Stickl H (1975) Abstammung, Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA. Infection 3: 6–14Google Scholar
  18. 17.
    Mayr A, Stickl H, Müller HK, Danner K, Singer H (1978) Der Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrung mit der parenteralen Schutzimpfung und Verhalten im abwehrgeschwächten Organismus. Zentralbl Bakteriol Mikrobiol Hyg [B] 167: 375–390Google Scholar
  19. 18.
    Messing J (1983) New M 13 vectors for cloning. Methods Enzymol 101: 20–78Google Scholar
  20. 19.
    Morgan JR, Roberts BE (1984) Organization of RNA transcripts from a vaccinia virus early gene cluster. J Virol 51: 283–297Google Scholar
  21. 20.
    Morita M, Aoyama Y, Arita M, Amano H, Yoshizawa H, Hashizume S, Komatsu T, Tagaya I (1977) Comparative studies of several vaccinia virus strains by intrathalmic inoculation into cynomolgus monkeys. Arch Virology 53: 197–208Google Scholar
  22. 21.
    Morita M, Suzuki K, Yasuda A, Kojima A, Sugimoto M, Watanabe K, Kobayashi H, Kajima K, Hashizume S (1987) Recombinant vaccinia virus LC 16m0 or LC 16m8 that express hepatitis B surface antigen while preserving the attenuation of the parental virus strain. Vaccine 5: 65–70Google Scholar
  23. 22.
    Moss B, Winters E, Cooper JA (1981) Deletion of a 9,000-base-pair segment of the vaccinia virus genome that encodes nonessential polypeptides. J Virol 40: 387–395Google Scholar
  24. 23.
    Panicali D, Paoletti E (1982) Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus. Proc Natl Acad Sci USA 79: 4927–4931Google Scholar
  25. 24.
    Parker RF, Bronson LH, Green RH (1941) Further studies of the infectious unit of vaccinia. J Exp Med 74: 263–281Google Scholar
  26. 25.
    Perkus ME, Panicali D, Mercer S, Paoletti E (1986) Insertion and deletion mutants of vaccinia virus. Virology 152: 285–297Google Scholar
  27. 26.
    Plucienniczak A, Schröder E, Zettelmeissel G, Streeck RE (1985) Nucleotide sequence of a cluster of early and late genes in a conserved segment of the vaccinia virus genome. Nucleic Acids Res 13: 985–998Google Scholar
  28. 27.
    Sanger F, Coulsen AR, Barell BG, Smith AJH, Roe BA (1980) Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol 143: 161–178Google Scholar
  29. 28.
    Schröder CH, Urbaczka G (1978) Excess of interfering over infectious particles in herpes simplex virus passaged at high m.o.i. and their effect on single-cell survival. J Gen Virol 41: 493–501Google Scholar
  30. 29.
    Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503–517Google Scholar
  31. 30.
    Stickl H, Hochstein-Mintzel A, Mayr A, Huber HC, Schäfer H, Holzner A (1974) MVA-Stufenimpfung gegen Pocken: klinische Erprobung des attenuierten Pocken-Lebendimpfstoffes, Stamm MVA. Dtsch Med Wochenschr 99: 2386–2392Google Scholar
  32. 31.
    Sugimoto M, Yasuda A, Miki K, Morita M, Suzuki K, Uchida N, Hashizume S (1985) Gene structures of low-neurovirulent vaccinia virus LC 16m0, LC 16m8, and their Lister original (LO) strains. Microbiol Immunol 29: 421–428Google Scholar
  33. 32.
    Tamin A, Villarreal EC, Weinrich SL, Hruby DE (1988) Nucleotide sequence and molecular genetic analysis of the vaccinia virus HindIII N/M region encoding the genes responsible for resistance to α-amanitin. Virology 165: 141–150Google Scholar
  34. 33.
    van der Noordaa J, Dekking F, Posthuma J, Beunders BJW (1967) Primary vaccination with an attenuated strain of vaccinia virus. Arch Ges Virusforsch 22: 210–214Google Scholar
  35. 34.
    Villareal EC, Hruby DE (1986) Mapping and location of the gene encoding α-amanitin resistance in vaccinia virus mutants. J Virol 57: 65–70Google Scholar
  36. 35.
    Weir JP, Moss B (1984) Regulation of expression and nucleotide sequence of a late vaccinia virus gene. J Virol 51: 662–669Google Scholar
  37. 36.
    Wittek R (1982) Organization and expression of the poxvirus genome. Experientia 38: 285–297Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • W. Altenburger
    • 1
  • C-P. Süter
    • 1
  • Judit Altenburger
    • 1
  1. 1.Central Research UnitsF. Hoffmann-La Roche & Co.BaselSwitzerland

Personalised recommendations